BORA PHARMACEUTICALS LTD Free Cash Flow Generation Index
BORA PHARMACEUTICALS LTD free cash flow generation index. BORA PHARMACEUTICALS LTD (6472) has a Free Cash Flow Generation Index of 0.63x as of March 2026. Free cash flow of NT$357.38 Million represents 1% of operating cash flow (NT$568.46 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of BORA PHARMACEUTICALS LTD (2019–2025)
Free cash flow generation index of BORA PHARMACEUTICALS LTD from 2019 to 2025. Historical FCF Generation Index trend for BORA PHARMACEUTICALS LTD across 7 annual periods. See BORA PHARMACEUTICALS LTD leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
BORA PHARMACEUTICALS LTD Free Cash Flow Generation Index by Year (2019–2025)
BORA PHARMACEUTICALS LTD free cash flow generation index by year from 2019 to 2025. Year-by-year Free Cash Flow Generation Index for BORA PHARMACEUTICALS LTD. For the full cash flow conversion analysis, see how efficiently does BORA PHARMACEUTICALS LTD generate cash.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | NT$3.31 Billion | NT$4.24 Billion | NT$928.67 Million | ▲ +160.8% |
| 2024 | 0.30x | NT$293.76 Million | NT$980.81 Million | NT$687.05 Million | ▼ -56.6% |
| 2023 | 0.69x | NT$3.18 Billion | NT$4.61 Billion | NT$1.43 Billion | ▼ -23.4% |
| 2022 | 0.90x | NT$1.81 Billion | NT$2.01 Billion | NT$200.22 Million | ▲ +27.5% |
| 2021 | 0.71x | NT$873.05 Million | NT$1.24 Billion | NT$363.58 Million | ▲ +388.4% |
| 2020 | 0.14x | NT$25.70 Million | NT$177.79 Million | NT$152.09 Million | ▲ +107.2% |
| 2019 | -2.01x | NT$-465.56 Million | NT$231.77 Million | NT$697.33 Million | — |